Financhill
Back

Surgery Partners Quote, Financials, Valuation and Earnings

Surgery Partners Price Quote

$26.61
+0.02 (+-1.84%)
(Updated: May 11, 2024 at 6:26 AM ET)

Surgery Partners Key Stats

Buy
57
Surgery Partners (SGRY) is a Buy

Day range:
$26.50 - $27.57
52-week range:
$22.05 - $45.79
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.20
P/B ratio:
1.72%

Volume:
1M
Avg. volume:
941.9K
1-year change:
-26.08%
Market cap:
$3.4B
Revenue:
$2.7B
EPS:
$0

How Much Does Surgery Partners Make?

Is Surgery Partners Growing As A Company?

  • What Is Surgery Partners's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.08%
  • What Is Surgery Partners's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Surgery Partners Stock Price Performance

  • Did Surgery Partners Stock Go Up Last Month?
    Surgery Partners share price went up by 1.26% last month
  • Did SGRY's Share Price Rise Over The Last Year?
    SGRY share price fell by -26.08% over the past 1 year

What Is Surgery Partners 52-Week High & Low?

Surgery Partners Price To Free Cash Flow

Is It Risky To Buy Surgery Partners?

  • How Much Debt Does Surgery Partners Have?
    Total long term debt quarterly is $2.9B
  • How Much Cash Does Surgery Partners Have?
    Cash and short term investments quarterly total is $185.2M
  • What Is Surgery Partners’s Book Value Per Share?
    Book value per share is 15.48

Is Surgery Partners Cash Flow Positive?

  • What Is SGRY Cash Flow From Operations?
    Cash flow from operations (TTM) is $260M
  • What Is Surgery Partners’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$82.3M
  • What Is Surgery Partners’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$238M

Surgery Partners Return On Invested Capital

  • Is Management Doing A Good Job?
    SGRY return on invested capital is 0.01%
  • What Is Surgery Partners Return On Assets?
    ROA measures how assets are converting to revenues and is 0.01%
  • What Is SGRY Return On Equity?
    ROE is a measure of profitability and is 0.02%

Surgery Partners Earnings Date & Stock Price

Surgery Partners Competitors

  • Who Are Surgery Partners's Competitors?
    Below is a list of companies who compete with Surgery Partners or are related in some way:
    • American Oncology Network Inc (AONC)
    • DaVita Inc (DVA)
    • Encompass Health Corp (EHC)
    • Healthcare Services Group Inc (HCSG)
    • The Oncology Institute Inc (TOI)

Surgery Partners Dividend Yield

Data Unavailable

Surgery Partners Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 27.7%
Revenue: 7.69% 2.4%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 41.09
Upside from Last Price: 54.54%

Major Shareholders

  • How many SGRY shares are owned by institutional investors?
    200.3M SGRY shares are owned by institutional investors
  • How many SGRY shares are owned by insiders?
    5.3M SGRY shares are owned by insiders